Transcripts
Innate Pharma (IPHA) earnings call transcripts
Earnings call transcripts for Innate Pharma S.A., with a summary, the guidance given, and what analysts pressed on.
- Q4 2026 earnings call
Management framed the half around executing three catalysts, with the SOBI deal strengthening funding and early ADC activity still awaiting fuller data.
Date n/aPositive0.68